D
Lantern Pharma Inc. LTRN
$3.93 $0.133.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Very Weak
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 2.11
Price History LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 7.38%
30-Day Total Return -15.85%
60-Day Total Return 14.58%
90-Day Total Return 19.82%
Year to Date Total Return 19.09%
1-Year Total Return -60.54%
2-Year Total Return -15.48%
3-Year Total Return -43.53%
5-Year Total Return --
52-Week High % Change -67.22%
52-Week Low % Change 40.86%
Price LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $11.99
52-Week Low Price $2.79
52-Week Low Price (Date) Nov 21, 2024
52-Week High Price (Date) Mar 25, 2024
Valuation LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 42.38M
Enterprise Value 14.62M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -1.78
Earnings Per Share Growth 27.41%
Price/Earnings To Growth --
Price/Sales (TTM) --
Price/Book (Q) 1.59
Enterprise Value/Revenue (TTM) --
Price $3.93
Enterprise Value/EBITDA (TTM) -0.69
Enterprise Value/EBIT -0.69
Market Cap Category Nano Cap
Dividends and Shares LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 10.76M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 972 277 1136
Address 1920 McKinney Avenue Dallas, TX 75201
Website www.lanternpharma.com
Country United States
Year Founded 2013
Profitability LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) --
Profit Margin --
Management Effectiveness LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -33.94%
Return on Equity --
Income Statement LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) --
Revenue Per Share --
Gross Profit (TTM) --
EBITDA (TTM) -21.18M
EBIT (TTM) -21.20M
Net Income (TTM) -19.09M
Net Income Avl. to Common (TTM) -19.09M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) -42.52%
EPS Diluted (TTM) -1.78
EPS Diluted Growth (Q YOY) -43.75%
Balance Sheet LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 28.05M
Cash Per Share (Q) $2.61
Total Current Assets (Q) 29.92M
Total Preferred Equity (Q) --
Total Equity (Q) 26.60M
Current Ratio (Q) 8.309
Book Value Per Share (Q) $2.47
Total Assets (Q) 30.29M
Total Current Liabilities (Q) 3.60M
Total Debt (Q) 291.20K
Total Liabilities (Q) 3.70M
Total Common Equity (Q) 26.60M
Cash Flow LTRN - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) 178.20K
Cash from Financing (TTM) -433.30K
Net Change in Cash (TTM) -17.47M
Levered Free Cash Flow (TTM) -10.41M
Cash from Operations (TTM) -17.23M
Weiss Ratings